Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers (clinicaltrials.gov) - Oct 22, 2026 - P2 | N=30 | Active, not recruiting | Sponsor: Dana-Farber Cancer Institute | Trial completion date: Jun 2026 ➔ Jul 2027
Trial completion date • Brain Cancer • Chordoma • Kidney Cancer • Oncology • Renal Cell Carcinoma • Rhabdoid Tumor • Sarcoma • Soft Tissue Sarcoma • Solid Tumor • SMARCB1
|